Brief: Medicure Places PREXXARTAN Oral Solution Project On Hold
19/03/2018 11:38
March 19 (Reuters) - Medicure Inc MPH.V :
* MEDICURE - PLACED PREXXARTAN ORAL SOLUTION PROJECT ON HOLD
PENDING RESOLUTION OF DISPUTE BETWEEN OWNER OF NDA, CARMEL
BIOSCIENCES, OTHERS
Source text for Eikon: ID:nPn8dL69Ta
Further company coverage: MPH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicure
See all newsBrief: Medicure Announces Resignation Of Board Member And Grant Of Stock Options
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021